Skin of Color pp 181-210 | Cite as




Keloidal scarring has been described by many cultures dating back as far as the Smith Papyrus in 3000 bc. The Yoruba tribe of Western Africa gives us perhaps the most complete record of ancient knowledge with their painting and sculpture of keloids circa 1600 ad. Despite this long history of knowledge and the explosion of medical care in other arenas, we have made minimal progress since the Yorubas toward understanding keloid prevention and eradication. No small measure of our current lack of consistently reliable, safe treatment measures is grounded in our ignorance of keloid pathogenesis. Prevention, too, is hampered by aspects of keloid occurrence that are out of our control. One can avoid trauma resulting from voluntary and elective procedures to adorn, augment, or improve. Aggressive prevention of keloids after accidental trauma and necessary surgery is also potentially within our abilities. However, most aspects of keloid formation are out of our control: ethnicity, skin pigmentation, age, gender, and genetic makeup. This chapter will briefly review what is known about keloid epidemiology and pathogenesis in an effort to gain insight into the development of a rational treatment and prevention plan for these unsightly lesions.


Hypertrophic Scar Keloidal Scarring Acne Lesion Keloidal Fibroblast Keloid Formation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Breasted JH. The Edwin Smith surgical papyrus, vol I: hieroglyphic translation and commentary. Chicago: University of Chicago Press; 1930. p. 403–6.Google Scholar
  2. 2.
    Omo-Dare P. Yoruban contribution to literature on keloids. J Nat Med Assoc. 1973;65:367–406.Google Scholar
  3. 3.
    Bloom D. Heredity of keloids: review of the literature and report of a family with multiple keloids for five generations. N Y State J Med. 1956;56:511.PubMedGoogle Scholar
  4. 4.
    Abrahms B, Benedetto A, Humeniuk H. Exuberant keloidal formation. J AOAC Int. 1993;93:863–5.Google Scholar
  5. 5.
    Brenizer A. Keloid formation in the Negro. Ann Surg. 1915;61:87.CrossRefGoogle Scholar
  6. 6.
    Fox H. Observations on skin diseases in the American Negro. J Cutan Dis. 1908;26:67.Google Scholar
  7. 7.
    Alhady SM, Sivanantharajah K. Keloids in various races; a review of 175 cases. Plast Reconstr Surg. 1969;44:564.PubMedCrossRefGoogle Scholar
  8. 8.
    Arnold H, Graver F. Keloids: etiology and management. Arch Dermatol. 1959;80:772.PubMedCrossRefGoogle Scholar
  9. 9.
    Kelly P. Keloids. Dermatol Clin. 1988;6:413–24.PubMedGoogle Scholar
  10. 10.
    Rockwell W, Cohen I, Erlich H. Keloids and hypertrophic scars. A comprehensive review. Plast Reconstr Surg. 1989;84:827–37.PubMedCrossRefGoogle Scholar
  11. 11.
    Davies D. Scars, hypertrophic scars and keloids. Plast Reconstr Surg. 1985;290:1056–8.Google Scholar
  12. 12.
    Chipev C, Simman R, Hatch G, Katz A, Siegel D, Simon A. Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ. 2000;7:166–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Flint M. The biological basis of Langer’s lines. In: Longacre JJ, editor. The ultrastructure of collagen. Springfield: Charles C Thomas; 1976. p. 132–40.Google Scholar
  14. 14.
    Stucker F, Shaw G. An approach to management of keloids. Arch Otolaryngol Head Neck Surg. 1992;118:63–7.PubMedCrossRefGoogle Scholar
  15. 15.
    Asboe-Hansen G. Hypertrophic scars and keloids; etiology, pathogenesis and dermatologic therapy. Dermatologia. 1960;120:178.CrossRefGoogle Scholar
  16. 16.
    Kormoczy B. Enormous keloid(?) on a penis. Br J Plast Surg. 1978;31:268.PubMedCrossRefGoogle Scholar
  17. 17.
    Garb J, Stone M. Keloids: review of the literature and a report of eighty cases. Am J Surg. 1942;58:315.CrossRefGoogle Scholar
  18. 18.
    Baldwin H. Personal communication. 2000.Google Scholar
  19. 19.
    Lane J, Waller J, Davis L. Relationship between age of ear piercing and keloid formation. Pediatrics. 2005;115:1312–4.PubMedCrossRefGoogle Scholar
  20. 20.
    Cosman B, Crikelair G, Ju M, Gaulin J, Lattes R. The surgical treatment of keloids. Plast Reconstr Surg. 1961;27:335–45.CrossRefGoogle Scholar
  21. 21.
    Abergel R, Pizzurro D, Meeker C, et al. Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol. 1985;84:384–90.PubMedCrossRefGoogle Scholar
  22. 22.
    Cohen I, Keiser H, Sjoerdsma A. Collagen synthesis in human keloid patients. Plast Reconstr Surg. 1979;63:689.PubMedCrossRefGoogle Scholar
  23. 23.
    Tan E, Rouda S, Greenbaum S, Moore J, Fox J, et al. Acidic and basic fibroblast growth factors down regulate collagen gene expression in keloid fibroblasts. Am J Pathol. 1993;142:463–70.PubMedGoogle Scholar
  24. 24.
    Diegelmann R, Bryant C, Cohen I. Tissue alpha globulins in keloid formation. Plast Reconstr Surg. 1977;59:481.Google Scholar
  25. 25.
    Bauer E, Eisen A, Jeffrey J. Regulation of vertebrate collagenase activity in vivo and in vitro. J Invest Dermatol. 1972;59:50–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Sayah DN, Soo C, Shaw WW, Watson J, Messadi D, et al. Downregulation of apoptosis-related genes in keloid tissues. J Surg Res. 1999;87:209–16.PubMedCrossRefGoogle Scholar
  27. 27.
    AkasakaY FK, Ishikawa Y, Asuwa N, Inuzuka K, et al. Detection of apoptosis in keloids and a comparative study on apoptosis between keloids, hypertrophic scars, normal healed fibrotic scars, and dermatofibroma. Wound Repair Regen. 2001;9:501–6.CrossRefGoogle Scholar
  28. 28.
    Shaffer J, Taylor S, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol. 2002;46:S63–97.PubMedCrossRefGoogle Scholar
  29. 29.
    Mustoe T, Cooter R, Gold M, Hobbs F, Ramelet A, et al. International clinical recommendations on scar management. Plast Reconstr Surg. 2002;110:560–71.PubMedCrossRefGoogle Scholar
  30. 30.
    Durani P, Bayat A. Levels of evidence for the treatment of keloid disease. J Plast Reconstr Aesthet Surg. 2008;61:4–17.PubMedCrossRefGoogle Scholar
  31. 31.
    Lenventhal D, Furr M, Reiter D. Treatment of keloids and hypertrophic scars: a meta-analysis and review of the literature. Arch Facial Plast Surg. 2006;8:362–8.CrossRefGoogle Scholar
  32. 32.
    Border W, Noble N. TGF-B. Sci Am Sci Med. 1995;2:68–77.Google Scholar
  33. 33.
    Kauh Y, Rouda S, Mondragon G, et al. Major suppression of pro-alpha 19(I) type I collagen gene expression in the dermis after keloid excision and immediate intrawound injection of triamcinolone acetonide. J Am Acad Dermatol. 1997;37:586–9.PubMedCrossRefGoogle Scholar
  34. 34.
    Kiil J. Keloids treated with topical injections of triamcinolone acetonide (Kenalog): immediate and long term results. Scand J Plast Reconstr Surg. 1977;11:169–72.PubMedCrossRefGoogle Scholar
  35. 35.
    Griffith B, Monroe C, McKinney P. A follow-up study on the treatment of keloids with triamcinolone acetonide. Plast Reconstr Surg. 1970;46:145–50.PubMedCrossRefGoogle Scholar
  36. 36.
    Lahiri A, Tsiliboti D, Gaze N. Experience with difficult keloids. Br J Plast Surg. 2001;54:633–5.PubMedCrossRefGoogle Scholar
  37. 37.
    Lawrence W. In search of the optimal treatment of keloids: report of a series and a review of the literature. Ann Plast Surg. 1991;27:164–78.PubMedCrossRefGoogle Scholar
  38. 38.
    Yosipovitch G, Widijanti Sugene M, Goon A, Chan Y, Goh C. A Comparison of the combined effect of cryotherapy and corticosteroid injections versus corticosteroids and cryotherapy on keloids: a controlled study. J Dermatol Treat. 2001;12:87–90.CrossRefGoogle Scholar
  39. 39.
    Berman B, Flores F. Recurrence rates of excised keloids treated with post operative triamcinolone injections of interferon alpha 2b. J Am Acad Dermatol. 1997;37:755–7.PubMedCrossRefGoogle Scholar
  40. 40.
    Lee J, Kim S, Lee A. Effects of interferon-alpha2b on keloid treatment with triamcinolone acetonide intralesional injection. Int J Dermatol. 2008;47:183–6.PubMedCrossRefGoogle Scholar
  41. 41.
    Akoz T, Gideroglu K, Akan M. Combination of different techniques for the treatment of earlobe keloids. Aesthetic Plast Surg. 2002;26:184–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Darzi M, Chowdi N, Kaul S, et al. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year follow-up study. Br J Plast Surg. 1992;45:374–9.PubMedCrossRefGoogle Scholar
  43. 43.
    Cheng L. Keloid of the earlobe. Laryngoscope. 1974;82:673–81.CrossRefGoogle Scholar
  44. 44.
    Ogawa R, Miyashita T, Hyakusoku H, Akaishi S, Kuribayashi S, et al. Postoperative radiation protocol for keloids and hypertrophic scars: statistical analysis of 370 sites followed for over 18 months. Ann Plast Surg. 2007;59:688–91.PubMedCrossRefGoogle Scholar
  45. 45.
    Narkwong L, Thirakhupt P. Postoperative radiotherapy with high dose rate iridium 192 mould for prevention of earlobe keloids. J Med Assoc Thai. 2006;89:428–33.PubMedGoogle Scholar
  46. 46.
    Rauscher G, Kolmer W. Treatment of recurrent earlobe keloids. Cutis. 1996;38:67–8.Google Scholar
  47. 47.
    Sclafani A, Gordon L, Chadha M, Romo T. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy. Dermatol Surg. 1996;22:569–74.PubMedCrossRefGoogle Scholar
  48. 48.
    Shons A, Press B. The treatment of earlobe keloids by surgical excision and postoperative triamcinolone injection. Ann Plast Surg. 1983;10:480–2.PubMedCrossRefGoogle Scholar
  49. 49.
    Rosen D, Patel M, Freeman K, Weiss P. A primary protocol for the management of ear keloids: results of excision combined with intraoperative and postoperative steroid injections. Plast Reconstr Surg. 2007;120:1395–400.PubMedCrossRefGoogle Scholar
  50. 50.
    Akita S, Akino K, Yakabe A, Imaizumi T, Tanaka K, et al. Combined surgical excision and radiation therapy for keloid treatment. J Craniofac Surg. 2007;18:1164–9.PubMedCrossRefGoogle Scholar
  51. 51.
    Ragoowansi R, Cornes P, Glees J, Powell B, Moss A. Earlobe keloids: treatment by a protocol of surgical excision and immediate postoperative adjuvant radiotherapy. Br J Plast Surg. 2001;54:504–8.PubMedCrossRefGoogle Scholar
  52. 52.
    Chaudhry M, Akhtar S, Duvalsaint F, Garner L, Lucente F. Earlobe keloids, surgical excision followed by radiation therapy: a 10-year experience. Ear Nose Throat J. 1994;73:779–81.PubMedGoogle Scholar
  53. 53.
    Salasche S, Grabski W. Keloids of the earlobe: a surgical technique. J Dermatol Surg Oncol. 1983;9:552–6.PubMedGoogle Scholar
  54. 54.
    Kantor G, Wheeland R, Bailin P, Walker N, Ratz J. Treatment of earlobe keloids with carbon dioxide laser excision: a report of 16 cases. J Dermatol Surg Oncol. 1985;11:1063–7.PubMedGoogle Scholar
  55. 55.
    Driscoll B. Treating keloids with carbon dioxide lasers. Arch Otolaryngol Head Neck Surg. 2001;127:1145.PubMedGoogle Scholar
  56. 56.
    Alster T. Laser treatment of hypertrophic scars, keloids and striae. Dermatol Clin. 1997;15:419–29.PubMedCrossRefGoogle Scholar
  57. 57.
    ApfelbergD MM, White D, Lash H. Failure of carbon dioxide laser excision of keloids. Lasers Surg Med. 1989;9:382–8.CrossRefGoogle Scholar
  58. 58.
    Sherman R, Rosenfeld H. Experience with the NDYAG laser in the treatment of keloid scars. Ann Plast Surg. 1988;24:231–3.CrossRefGoogle Scholar
  59. 59.
    Conejo-Mir JS. Carbon dioxide laser ablation in association with interferon alfa-2b injections reduces the recurrence of keloids. J Am Acad Dermatol. 1998;39:1039–40.PubMedCrossRefGoogle Scholar
  60. 60.
    Alster T, Williams C. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet. 1995;345:118–200.CrossRefGoogle Scholar
  61. 61.
    Connell P, Harland C. Treatment of keloid scars with pulsed dye laser and intralesional steroids. J Cutan Laser Ther. 2000;2:147–59.PubMedGoogle Scholar
  62. 62.
    Maniskiatti W, Fitzpatrick R. Treatment response of keloidal and hypertrophic, sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol. 2002;138:1149–55.CrossRefGoogle Scholar
  63. 63.
    Asilian A, Darougheh A, Shariati F. New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg. 2006;32:907–15.PubMedCrossRefGoogle Scholar
  64. 64.
    Alster T, Handrick C. Laser treatment of hypertrophic scars, keloids and striae. Semin Cutan Med Surg. 2000;19:287–92.PubMedCrossRefGoogle Scholar
  65. 65.
    Order S, Donaldsen S. Radiation therapy for benign disease. Berlin: Springer; 1990. p. 147–53.Google Scholar
  66. 66.
    Borok T, Brav M, Sinclair I, Plafker J, LaBirth L. Role of ionizing irradiation for 393 keloids. Int J Radiat Oncol Biol Phys. 1988;15:865–70.PubMedCrossRefGoogle Scholar
  67. 67.
    Brown J, Bromberg JH. Preliminary studies on the effect of time-dose patterns in the treatment of keloids. Radiology. 1963;80:298–302.PubMedGoogle Scholar
  68. 68.
    Edsmyr F, Larsoon L, Onyango J, Wanguru S, Wood M. Radiotherapy in the treatment of keloids in East Africa. East Afr Med J. 1973;50:457–61.PubMedGoogle Scholar
  69. 69.
    Garth J, Stone M. Keloids: review of literature and a report of 80 cases. Am J Surg. 1942;58:315–35.CrossRefGoogle Scholar
  70. 70.
    Lo T, Seckel B, Salzman F, et al. Single-dose electron beam irradiation in treatment and prevention of keloids and hypertrophic scars. Radiother Oncol. 1990;19:267–72.PubMedCrossRefGoogle Scholar
  71. 71.
    Ollstein R, Siegel H, Gillooley J, et al. Treatment of keloids by combined surgical excision and immediate post-operative X-ray therapy. Ann Plast Surg. 1981;7:281–5.PubMedCrossRefGoogle Scholar
  72. 72.
    Khumpar D, Murray J, Anscher M. Keloids treated with excision followed by radiation therapy. J Am Acad Dermatol. 1994;31:225–31.CrossRefGoogle Scholar
  73. 73.
    Darzi M, Chowdi N, Kaul S, Kahn M. Evaluation of various methods of treating keloids and hypertrophic scars: a 10-year experience. Int J Radiat Oncol Biol Phys. 1989;17:77–80.Google Scholar
  74. 74.
    Botwood N, Lewanski C, Lowdell C. The risks of treating keloids with radiotherapy. Br J Radiol. 1999;72:1222–4.PubMedGoogle Scholar
  75. 75.
    Kal H, Veen R. Biologically effective doses of postoperative radiotherapy in the prevention of keloids. Dose-effect relationship. Strahlenther Onkol. 2005;181:717–23.PubMedCrossRefGoogle Scholar
  76. 76.
    Guix B, Henriquez I, Andres A, Finestres F, Tello J, et al. Treatment of keloids by high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys. 2001;50:167–72.PubMedCrossRefGoogle Scholar
  77. 77.
    Escarmant P, Zimmerman S, Amar A, et al. The treatment of 783 keloid scars by iridium 192 interstitial radiation after surgical excision. Int J Radiat Oncol Biol Phys. 1993;26:245–51.PubMedCrossRefGoogle Scholar
  78. 78.
    Maarouf M, Schleicher U, Schmachtenberg A, Ammon J. Radiotherapy in the management of keloids. Clinical experience with electron beam irradiation and comparison with X-ray therapy. Strahlenther Onkol. 2002;178:330–5.PubMedCrossRefGoogle Scholar
  79. 79.
    Bischof M, Krempien R, Debus J, Treiber M. Postoperative electron beam radiotherapy for keloids: objective findings and patient satisfaction in self-assessment. Int J Dermatol. 2007;46:971–5.PubMedCrossRefGoogle Scholar
  80. 80.
    Ogawa R, Mitsuhashi K, Hyakusoku H, Miyashita T. Postoperative electron-beam irradiation therapy for keloids and hypertrophic scars: retrospective study of 147 cases followed for more than 18 months. Plast Reconstr Surg. 2003;111:547–53.PubMedCrossRefGoogle Scholar
  81. 81.
    Wagner W, Alfrink M, Micke O, Schafer U, Schuller P, et al. Results of prophylactic irradiation in patients with resected keloids: a retrospective analysis. Acta Oncol. 2000;39:217–20.PubMedCrossRefGoogle Scholar
  82. 82.
    Mizuno H, Cagri Uysal A, Koike S, Hyakusoku H. Squamous cell carcinoma of the auricle arising from keloid after radium needle therapy. J Craniofac Surg. 2006;17:360–2.PubMedCrossRefGoogle Scholar
  83. 83.
    Bilbey J, Muller N, Miller R, Nelemus B. Localised fibrous mesothelioma of pleura following external ionising radiation therapy. Chest. 1988;94:1291–2.PubMedCrossRefGoogle Scholar
  84. 84.
    Hoffman S. Radiotherapy for keloids? Ann Plast Surg. 1982;9:265.PubMedCrossRefGoogle Scholar
  85. 85.
    Sampson R, Kev C, Buschler C, Iijima S. Thyroid carcinoma and radiation. JAMA. 1969;209:65.PubMedCrossRefGoogle Scholar
  86. 86.
    Doornbos J, Stoffel T, Hass A, Hussey D, Vigliotti A, et al. The role of kilovoltage irradiation in the treatment of keloids. Int J Radiat Oncol Biol Phys. 1990;18:833–8.PubMedCrossRefGoogle Scholar
  87. 87.
    Kosaka M, Kamiishi H. New concept of balloon-compression wear for the treatment of keloids and hypertrophic scars. Plast Reconstr Surg. 2001;108:1454–5.PubMedCrossRefGoogle Scholar
  88. 88.
    Gold M. A controlled clinical trial of topical silicone gel sheeting in the treatment of hypertrophic scars and keloids. J Am Acad Dermatol. 1994;30:506–7.PubMedCrossRefGoogle Scholar
  89. 89.
    Fulton J. Silicone gel sheeting for the prevention and management of evolving hypertrophic and keloid scars. Dermatol Surg. 1995;21:947–51.PubMedCrossRefGoogle Scholar
  90. 90.
    Ahn S, Monafo W, Mustoe T. Topical silicone gel: a new treatment for hypertrophic scars. Surgery. 1989;106:781–6.PubMedGoogle Scholar
  91. 91.
    Berman B, Perez O, Konda S, et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatol Surg. 2007;33:1291–302.PubMedCrossRefGoogle Scholar
  92. 92.
    Mustoe T. Evolution of silicone therapy and mechanism of action in scar management. Aesthetic Plast Surg. 2008;32:82–92.PubMedCrossRefGoogle Scholar
  93. 93.
    Signorini M, Clementoni M. Clinical evaluation of a new self-drying silicone gel in the treatment of scars: a preliminary report. Aesthetic Plast Surg. 2007;31(2):183–7.PubMedCrossRefGoogle Scholar
  94. 94.
    Viana de Oliveira G, Nunes T, Magna L, Cintra M, Kitten G, et al. Silicone versus nonsilicone gel dressings: a controlled trial. Dermatol Surg. 2001;27:721–6.CrossRefGoogle Scholar
  95. 95.
    Berman N, Duncan M. Short-term keloid treatment in vivo with human interferon alfa-2b results in a selective and persistent normalization of keloidal fibroblast collagen glycosaminoglycans and collagenase production in vitro. J Am Acad Dermatol. 1989;21:L694.CrossRefGoogle Scholar
  96. 96.
    Jacob S, Berman B, Vincek V. Topical application of imiquimod 5% cream to keloids alters expression genes associated with apoptosis. Br J Dermatol. 2008;149:62–5.CrossRefGoogle Scholar
  97. 97.
    Granstein R, Rook A, Flotte T, et al. Intralesional interferon gamma treatment for keloids and hypertrophic scars. Arch Otolaryngol Head Neck Surg. 1990;118:1159–62.Google Scholar
  98. 98.
    Granstein R. personal communication. New York Academy of Science; 1996.Google Scholar
  99. 99.
    Berman B, Bieley H. Adjunct therapies of surgical management of keloids. Dermatol Surg. 1996;22:126–30.PubMedCrossRefGoogle Scholar
  100. 100.
    Berman B, Kaufman J. Pilot study of the effect of postoperative imiquimod 5 % cream recurrence rate of excised keloids. J Am Acad Dermatol. 2002;47:S209–11.PubMedCrossRefGoogle Scholar
  101. 101.
    Stashower M. Successful treatment of earlobe keloids with imiquimod after tangential shave excision. Dermatol Surg. 2006;32:380–6.PubMedCrossRefGoogle Scholar
  102. 102.
    Martin-Garcia R, Busquets A. Postsurgical use of imiquimod 5 % cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study. Dermatol Surg. 2005;31:1394–8.PubMedCrossRefGoogle Scholar
  103. 103.
    Chuangsuwanich A, Gunjittisomram S. The efficacy of 5% imiquimod cream in the prevention of recurrence of excised keloids. J Med Assoc Thai. 2007;90:1363–7.PubMedGoogle Scholar
  104. 104.
    Malhotra A, Gupta S, Khaitan B, Sharma V. Imiquimod 5% cream for the prevention of recurrence after excision of presternal keloids. Dermatology. 2007;215:63–5.PubMedCrossRefGoogle Scholar
  105. 105.
    Rusciani L, Rossi G, Bono R. Use of cryotherapy in the treatment of keloids. J Dermatol Surg Oncol. 1993;19:529–34.PubMedGoogle Scholar
  106. 106.
    Zouboulis C, Blume U, Buttner P, Orfanos C. Outcomes of cryosurgery in keloids and hypertrophic scars. Arch Dermatol. 1993;129:1146–51.PubMedCrossRefGoogle Scholar
  107. 107.
    Gupta S, Kumar B. Intralesional cryosurgery using lumbar puncture and/or hypodermic needles for large, bulky, recalcitrant keloids. Int J Dermatol. 2001;40:349–53.PubMedCrossRefGoogle Scholar
  108. 108.
    Har-Shai Y, Amar M, Sabo E. Intralesional cryotherapy for enhancing the involution of hypertrophic scars and keloids. Plast Reconstr Surg. 2003;111:1841–52.PubMedCrossRefGoogle Scholar
  109. 109.
    Chowdri N, Masarat M, Mattoo A, Darzi M. Keloids and hypertrophic scars: results with intraoperative and serial postoperative corticosteroid injection therapy. Aust NZJ Surg. 1999;69:655–9.CrossRefGoogle Scholar
  110. 110.
    Fitzpatrick R. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg. 1999;25:224–32.PubMedCrossRefGoogle Scholar
  111. 111.
    Lebwohl M. From the literature. J Am Acad Dermatol. 1999;42:677.CrossRefGoogle Scholar
  112. 112.
    Gupta S, Kalra A. Efficacy and safety of intralesional 5-FU in the treatment of keloids. Dermatology. 2002;204:130.PubMedCrossRefGoogle Scholar
  113. 113.
    Kontochristopoulos K, et al. Intralesional 5-FU in the treatment of keloids: an open clinical and histopathologic study. J Am Acad Dermatol. 2005;52:474–9.PubMedCrossRefGoogle Scholar
  114. 114.
    Nanda R. Intralesional 5-FU as a treatment modality of keloids. Dermatol Surg. 2004;30:54–6.PubMedCrossRefGoogle Scholar
  115. 115.
    Apikian M, Goodman G. Intralesional 5-FU in the treatment of keloid scars. Australas J Dermatol. 2004;45:140–3.PubMedCrossRefGoogle Scholar
  116. 116.
    Beranek J, Masseyeff R. Hyperplastic capillaries and their possible involvement in the pathogenesis of fibrosis. Histopathology. 1992;10:543–51.CrossRefGoogle Scholar
  117. 117.
    Lawrence W. Treatment of earlobe keloids with surgery plus adjuvant intralesional verapamil and pressure earrings. Ann Plast Surg. 1996;37:167–9.PubMedCrossRefGoogle Scholar
  118. 118.
    Lee R, Dwong J, Jellema A. The response of burn scars to intralesional verapamil: report of five cases. Arch Surg. 1994;129:107–11.PubMedCrossRefGoogle Scholar
  119. 119.
    Phan T, See P, Tran E, Nguyen T, Chan S, et al. Suppression of insulin-like growth factor signaling pathway and collagen expression in keloid-derived fibroblasts by quercetin: a therapeutic potential use in the treatment and/or prevention of keloids. Br J Dermatol. 2003;148:544–52.PubMedCrossRefGoogle Scholar
  120. 120.
    Baumann L, Spencer J. The effects of topical vitamin E on the cosmetic appearance of scars. Dermatol Surg. 1999;25:311–5.PubMedCrossRefGoogle Scholar
  121. 121.
    Espana A, Solano T, Quintanilla E. Bleomycin in the treatment of keloids and hypertrophic scars by multiple needle punctures. Dermatol Surg. 2001;27:23–7.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.State University of New YorkBrooklynUSA

Personalised recommendations